Literature DB >> 27940916

Hierarchical CRMP2 posttranslational modifications control NaV1.7 function.

Erik T Dustrude1, Aubin Moutal1, Xiaofang Yang1, Yuying Wang1, May Khanna1, Rajesh Khanna2,3.   

Abstract

Voltage-gated sodium channels are crucial determinants of neuronal excitability and signaling. Trafficking of the voltage-gated sodium channel NaV1.7 is dysregulated in neuropathic pain. We identify a trafficking program for NaV1.7 driven by hierarchical interactions with posttranslationally modified versions of the binding partner collapsin response mediator protein 2 (CRMP2). The binding described between CRMP2 and NaV1.7 was enhanced by conjugation of CRMP2 with small ubiquitin-like modifier (SUMO) and further controlled by the phosphorylation status of CRMP2. We determined that CRMP2 SUMOylation is enhanced by prior phosphorylation by cyclin-dependent kinase 5 and antagonized by Fyn phosphorylation. As a consequence of CRMP2 loss of SUMOylation and binding to NaV1.7, the channel displays decreased membrane localization and current density, and reduces neuronal excitability. Preventing CRMP2 SUMOylation with a SUMO-impaired CRMP2-K374A mutant triggered NaV1.7 internalization in a clathrin-dependent manner involving the E3 ubiquitin ligase Nedd4-2 (neural precursor cell expressed developmentally down-regulated protein 4) and endocytosis adaptor proteins Numb and epidermal growth factor receptor pathway substrate 15. Collectively, our work shows that diverse modifications of CRMP2 cross-talk to control NaV1.7 activity and illustrate a general principle for regulation of NaV1.7.

Entities:  

Keywords:  CRMP2; NaV1.7 sodium channel; SUMOylation; phosphorylation; trafficking

Mesh:

Substances:

Year:  2016        PMID: 27940916      PMCID: PMC5206544          DOI: 10.1073/pnas.1610531113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  60 in total

1.  Molecular mechanisms of coupled monoubiquitination.

Authors:  Tanja Woelk; Barbara Oldrini; Elena Maspero; Stefano Confalonieri; Elena Cavallaro; Pier Paolo Di Fiore; Simona Polo
Journal:  Nat Cell Biol       Date:  2006-10-01       Impact factor: 28.824

2.  Cdk5-mediated phosphorylation of CRMP-2 enhances its interaction with CaV2.2.

Authors:  Joel M Brittain; Yuying Wang; Omotore Eruvwetere; Rajesh Khanna
Journal:  FEBS Lett       Date:  2012-09-26       Impact factor: 4.124

3.  Development and characterization of novel derivatives of the antiepileptic drug lacosamide that exhibit far greater enhancement in slow inactivation of voltage-gated sodium channels.

Authors:  Yuying Wang; Ki Duk Park; Christophe Salome; Sarah M Wilson; James P Stables; Rihe Liu; Rajesh Khanna; Harold Kohn
Journal:  ACS Chem Neurosci       Date:  2011-02-16       Impact factor: 4.418

4.  Injury-induced CRMP4 expression in adult sensory neurons; a possible target gene for ciliary neurotrophic factor.

Authors:  So Young Jang; Yoon Kyung Shin; Junyang Jung; Sang Hwa Lee; Su-Yeong Seo; Duk Joon Suh; Hwan Tae Park
Journal:  Neurosci Lett       Date:  2010-08-26       Impact factor: 3.046

5.  First evidence of overlaps between HIV-Associated Dementia (HAD) and non-viral neurodegenerative diseases: proteomic analysis of the frontal cortex from HIV+ patients with and without dementia.

Authors:  Li Zhou; Eve Diefenbach; Ben Crossett; Sieu L Tran; Thomas Ng; Helen Rizos; Rejane Rua; Bin Wang; Amit Kapur; Kaushal Gandhi; Bruce J Brew; Nitin K Saksena
Journal:  Mol Neurodegener       Date:  2010-06-24       Impact factor: 14.195

6.  CRMP-2 binds to tubulin heterodimers to promote microtubule assembly.

Authors:  Yuko Fukata; Tomohiko J Itoh; Toshihide Kimura; Céline Ménager; Takashi Nishimura; Takashi Shiromizu; Hiroyasu Watanabe; Naoyuki Inagaki; Akihiro Iwamatsu; Hirokazu Hotani; Kozo Kaibuchi
Journal:  Nat Cell Biol       Date:  2002-08       Impact factor: 28.824

7.  Collapsin response mediator protein 2 (CRMP2) interacts with N-methyl-D-aspartate (NMDA) receptor and Na+/Ca2+ exchanger and regulates their functional activity.

Authors:  Tatiana Brustovetsky; Jessica J Pellman; Xiao-Fang Yang; Rajesh Khanna; Nickolay Brustovetsky
Journal:  J Biol Chem       Date:  2014-01-28       Impact factor: 5.157

8.  Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin.

Authors:  G Fenteany; R F Standaert; W S Lane; S Choi; E J Corey; S L Schreiber
Journal:  Science       Date:  1995-05-05       Impact factor: 47.728

9.  ProTx-II, a selective inhibitor of NaV1.7 sodium channels, blocks action potential propagation in nociceptors.

Authors:  William A Schmalhofer; Jeffrey Calhoun; Rachel Burrows; Timothy Bailey; Martin G Kohler; Adam B Weinglass; Gregory J Kaczorowski; Maria L Garcia; Martin Koltzenburg; Birgit T Priest
Journal:  Mol Pharmacol       Date:  2008-08-26       Impact factor: 4.436

10.  Recent developments regarding voltage-gated sodium channel blockers for the treatment of inherited and acquired neuropathic pain syndromes.

Authors:  Jonathan W Theile; Theodore R Cummins
Journal:  Front Pharmacol       Date:  2011-10-04       Impact factor: 5.810

View more
  43 in total

1.  Modulator-Gated, SUMOylation-Mediated, Activity-Dependent Regulation of Ionic Current Densities Contributes to Short-Term Activity Homeostasis.

Authors:  Anna R Parker; Lori A Forster; Deborah J Baro
Journal:  J Neurosci       Date:  2018-11-30       Impact factor: 6.167

2.  CRMP2-Neurofibromin Interface Drives NF1-related Pain.

Authors:  Aubin Moutal; Li Sun; Xiaofang Yang; Wennan Li; Song Cai; Shizhen Luo; Rajesh Khanna
Journal:  Neuroscience       Date:  2018-04-12       Impact factor: 3.590

3.  CRMP2 Phosphorylation Drives Glioblastoma Cell Proliferation.

Authors:  Aubin Moutal; Lex Salas Villa; Seul Ki Yeon; Kyle T Householder; Ki Duk Park; Rachael W Sirianni; Rajesh Khanna
Journal:  Mol Neurobiol       Date:  2017-06-28       Impact factor: 5.590

4.  Phosphorylated CRMP2 Regulates Spinal Nociceptive Neurotransmission.

Authors:  Jie Yu; Aubin Moutal; Angie Dorame; Shreya S Bellampalli; Aude Chefdeville; Iori Kanazawa; Nancy Y N Pham; Ki Duk Park; Jill M Weimer; Rajesh Khanna
Journal:  Mol Neurobiol       Date:  2018-12-18       Impact factor: 5.590

5.  A single structurally conserved SUMOylation site in CRMP2 controls NaV1.7 function.

Authors:  Erik Thomas Dustrude; Samantha Perez-Miller; Liberty François-Moutal; Aubin Moutal; May Khanna; Rajesh Khanna
Journal:  Channels (Austin)       Date:  2017-02-28       Impact factor: 2.581

6.  Blocking CRMP2 SUMOylation reverses neuropathic pain.

Authors:  A Moutal; E T Dustrude; T M Largent-Milnes; T W Vanderah; M Khanna; R Khanna
Journal:  Mol Psychiatry       Date:  2018-11       Impact factor: 15.992

7.  Dynamic CRMP2 Regulation of CaV2.2 in the Prefrontal Cortex Contributes to the Reinstatement of Cocaine Seeking.

Authors:  William C Buchta; Aubin Moutal; Bethany Hines; Constanza Garcia-Keller; Alexander C W Smith; Peter Kalivas; Rajesh Khanna; Arthur C Riegel
Journal:  Mol Neurobiol       Date:  2019-07-29       Impact factor: 5.590

Review 8.  Mining the Nav1.7 interactome: Opportunities for chronic pain therapeutics.

Authors:  Lindsey A Chew; Shreya S Bellampalli; Erik T Dustrude; Rajesh Khanna
Journal:  Biochem Pharmacol       Date:  2019-01-27       Impact factor: 5.858

9.  The 2019 FASEB Science Research Conference on Ion Channel Regulation: Molecules to Disease, July 7-12, 2019, Lisbon, Portugal.

Authors:  Henry M Colecraft; Rajesh Khanna
Journal:  FASEB J       Date:  2020-03-11       Impact factor: 5.191

10.  Dissecting the role of the CRMP2-neurofibromin complex on pain behaviors.

Authors:  Aubin Moutal; Yue Wang; Xiaofang Yang; Yingshi Ji; Shizhen Luo; Angie Dorame; Shreya S Bellampalli; Lindsey A Chew; Song Cai; Erik T Dustrude; James E Keener; Michael T Marty; Todd W Vanderah; Rajesh Khanna
Journal:  Pain       Date:  2017-11       Impact factor: 6.961

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.